13
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Ocular disease leads to decreased concentrations of epidermal growth factor in the tear fluid

, , , , &
Pages 523-527 | Received 05 Nov 1990, Accepted 06 May 1991, Published online: 02 Jul 2009

References

  • Burstein N. L. Review: growth factor effects on corneal wound healing. J. Pharmacol. 1987; 264–277
  • Savage C. R., Cohen S. Proliferation of corneal epithelium induced by epidermal growth factor. Exp. Eye Res. 1973; IS: 361–366
  • Ho P. C., Davis W. H., Elliott J. H., Cohen S. Kinetics of epithelial regeneration and epidermal growth factor. Invest. Ophthalmol. 1974; 13: 804–813
  • Daniele S., Frati L., Fiore C., Santoni G. The effect of the epidermal growth factor (EGF) on the corneal epithelium in humans. Graefe's Arch. Clin. Exp. Ophthalmol. 1979; 210: 159–165
  • Brightwell J. R., Riddle S. L., Eiferman R. A., Valenzuela P., Barr P. J., Merryweather J. P., Schultz G. S. Biosynthetic human EGF accelerates healing of neodecadron-treated primate corneas. Invest. Ophthalmol. Vis. Sci. 1985; 21L: 105–110
  • Woost P. G., Brightwell J., Eiferman R. A., Schultz G. S. Effect of growth factors with dexamethasone on healing of rabbit corneal incisions. Exp. Eye Res. 1985; 4Q: 47–60
  • Calel B., Fagerholm P. Human epidermal growth factor–the influence on surgically closed wounds. Acta Ophthalmol. (Copenh) 1987; 65: 58–61, Suppl 1821
  • Schultz G. S., Davis J. B., Eiferman R. A. Growth factors and corneal epithelium. Portfolio Publishing Company of Texas, Inc The Cornea, Z, Woodlands, TX, USA 1988; 96–101
  • Pesonen K., Viinikka L., Koskimies A., Banks A. P., Nicolson M., Perheentupa J. Size heterogeneity, of epidermal growth factor in human body fluids. Life Sci. 1987; 4A: 2489–2494
  • Hayashi T., Sakamoto S. Radio-immuno assay of human epidermal growth factor -hEGF levels in human body fluids. J. Pharmacobio. Dyn. 1988; HQ.: 146–151
  • van Setten G. B., Viinikka L., Tervo T., Pesonen K., Tarkkanen A., Perheentupa J. Epidermal growth factor isa constant component of human tear fluid. Graefe's Arch. Clin. Exp. Ophthalmol. 1989; 221: 82–87
  • Ohasi Y., Motokura M., Kinoshita Y., Mano T., Watanabe H., Kinoshita S., Manabe R., Oshiden K., Yanaihara C. Presence of epidermal growth factor in human tears. Invest. Ophthalmol. Vis. Sci. 1989; 311: 1879–1882
  • van Setten G. B. Epidermal growth factor in human tear fluid: increased release but decreased concentrations during reflex tearing. Curr. Eye Res. 1990; fi: 79–83
  • Watanabe K., Ohashi Y., Kinoshita S., Danjo S., Manabe R., Yanaihara C., Oshiden K. Localization of epidermal growth factor in ocular and periocular tissues of rats. Invest. Ophthalmol. Vis. Sci. 1989; 30: 149, Suppl
  • van Setten G. B., Tervo K., Virtanen I., Tarkkanen A., Tervo T. Immuno-histochemical demonstration of epidermal growth factor in the lacrimal and submandibular glands of rats. Acta Ophthalmol. (Copenh.) 1990; fifi: 477–480
  • Pesonen K., Alfthan H., Stenman U. H., Viinikka L., Perheentupa J. An ultrasensitive time-resolved immunofluorometric assay of human epidermal growth factor. Anal. Biochem. 1986; 257: 208–214
  • Damato B. E., Allan D., Murray S. B., Lee W. R. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br. J. Ophthalmol. 1984; 68: 674–678
  • Elliott J. H. Epidermal growth factor: in vitro ocular studies. Trans. Am. Optom. Assoc. 1980; 2fi: 629–656
  • Das M. Epidermal growth factor: mechanisms of action. Int. Rev. Cytol. 1982; 25: 233–256
  • Steinemann T. L., Thompson H. W., Maroney K. M., Palmer C. H., Henderson L. A., Malter J. S., Clarke D., Bromberg B., Kunkle M., Beuerman R. W. Changes in epithelial epidermal growth factor receptor and lacrimal gland EGF concentration after corneal wounding. Invest. Ophthalmol. Vis. Sci. 1990; 31: 55, Supple
  • Chan K. Y. Release of plasminogen activator by cultured corneal epithelial cells during differentiation and wound healing. Exp. Eye Res. 1986; 42: 417–431
  • Tervo T., Salonen E. M., Vaheri A. A new therapy to promote corneal healing. Invest. Ophthalmol. Vis. Sci. 1987; 27: 53, Suppl.)
  • Tervo T., van Setten G. B. Aprotinin for inhibition of plasmin on the ocular surface: Principles and clinical observations. “Healing Processes of the Cornea”, R. W. Beuerman, C. E. Crosson, H. E. Kaufman. Portfolio Publishing Company of Texas, Inc., The Woodlands, TX, USA 1989; 151–163

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.